| VETLINE Larson Laboratories, Inc. |
 |
XXTERRA™ IS SOLD ONLY TO VETERINARIANS OR BY PRESCRIPTION |
XXTERRA™ was first used on a resident horse at the Colorado State university veterinary teaching hospital in Fort Collins, Colorado. A large sarcoid (8 1/2"W X 2"D) on the front leg below the carpus had been surgically removed several times, but returned after each removal, and had now been present for months Four days after applying XXTERRA™ under a bandage, the sarcoid appeared inflamed and was re-treated. Another four days later the bandage was removed and the tumor fell of the leg, leaving a depression with discrete edges and a serous scab covering. No further treatment was given, and the leg healed uneventfully. Since then, Larson and associates have successfully treated over 1000 sarcoids with XXTERRA™.
The local reaction to XXTERRA™ is consistent with a graft-reaction scenario, involving inflammation, pus underlying the tumor base, and tumor rejection. Ongoing studies have confirmed the presence of lymphoid cells in the pus. In an additional trial, a horse presented with four sarcoids, three of which were on the left side, with the forth on the right side. The left-side tumors were treated with XXTERRA™ and fell off in about 12 days. The lone right-side tumor remained untreated, but also sloughed off in about 10 more days. This suggests that specific sensitized cells forming on the left side of the horse had traveled systematically to attack the fourth tumor. These findings suggest an immune-mediated response similar to a graft-rejection reaction.
Up to 20% of sarcoids may return within 60 days after removal, but a second treatment with XXTERRA™ is usually effective. The less then 2% which return a third time, usually do not recur following a final treatment with XXTERRA™.
XXTERRA™ is an herbal formulation of bloodroot powder and zinc chloride solution, combined and stirred into a smooth brown paste. Bloodroot contains sanguinarine (the primary component), chelarathrine and protopine, all of which are alkaloids. Zinc chloride promotes inflammation of the sarcoids surface and with the alkaloids, alters the sarcoid cells so they become antigenic to the host. Accordingly, XXTERRA™ alters the antigenicity of a sarcoid to stimulate the host's immune system and result in an immune rejection reaction of the sarcoid.
 |
Sarcoid -DAY 1  |
 |
 |
 |
 |
 |
 |